Trademark: 97400931
Word
ORDOXTI
Status
Pending
Status Code
731
Status Date
Tuesday, March 19, 2024
Serial Number
97400931
Mark Type
4000
Filing Date
Monday, May 9, 2022
Published for Opposition
Tuesday, January 24, 2023

Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Trademark Events
Mar 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 19, 2024
Sou Extension 2 Granted
Mar 19, 2024
Sou Extension 2 Filed
Mar 19, 2024
Sou Teas Extension Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2023
Sou Extension 1 Granted
Aug 23, 2023
Sou Extension 1 Filed
Aug 23, 2023
Sou Teas Extension Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 21, 2022
Approved For Pub - Principal Register
Dec 19, 2022
Assigned To Examiner
Jul 14, 2022
Teas Change Of Correspondence Received
Jul 14, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 14, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 13, 2022
New Application Office Supplied Data Entered
May 12, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24